Good morning, folks. Nice to see you again. Seemingly pleasant skies are hovering over the Pharmalot corporate campus, where the birds are pooping on the official Pharmalot limousine and the mascots are fertilizing the weeds. As for us, we are hustling assorted short people off to their local schoolhouses and digging in for another busy day. We trust you have a similar agenda, which means there is no time to waste. So grab a cup of stimulation and peruse some tidbits. And, of course, have a grand day...
Vertex Exec Sold Stock Before The Bad News (Boston Globe)
Teva's New CEO Gets Off To A Shaky Start (Globes)
One In 10 Drugs Is Prescribed Off Label In Canada (McLean's)
An Insulin Fight Breaks Out Among Drugmakers (Reuters)
FDA Warns About Counterfeit Adderall Tablets (Reuters)
Lilly Backs Biotech Fund In Quebec (Montreal Gazette)
J&J Fails To Win FDA OK For Daily HIV Pill (Associated Press)
Bristol-Myers Forms Cancer Collaborations (Pharma Times)
KV Pharma Contacted By NYSE Over Stock Activity (St. Louis Business Journal)
Stada Seeks Deals For Growth (Reuters)
FDA Seeks Safety Report On Repros Tumor Drug (Reuters)
Human Genome Shareholder Sues Over Poison Pill (Pharma Times)
Endo Lobbies To Protect Its Big Seller (New York Times)
Nestor Plans Second Facility In Nigeria (Express Pharma)
EDITOR'S NOTE: Please check this post for updates






7 Comments
dz, you may have uncovered something highly significant. The Eye of Sauron bears a strong resemblance to the album cover for "Eye in the Sky" by The Alan Parsons Project. See comparison below.
This is an urgent matter and must be addressed poste haste.
http://en.wikipedia.org/wiki/File:Flag_of_Mordor.JRRT.jpg
http://seeker401.wordpress.com/2010/05/07/alan-parsons-project-eye-in-the-sky-album-cover/
Preliminary results found a striking association between the activity of biologic response modifiers which activate macrophages and the prior treatment status of patients with breast and ovarian cancers. Effective therapy produced a massive release and processing of tumor antigens, which led to a state in which the human immune system, via in situ cancer vaccination, responded to exogenous macrophage activation signals with potent and specific anti-tumor effects. It's a shame, good research going to waste. Not enough Bullion for BMS?